• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU454510
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 02/22/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Further information has been requested regarding the device.Awaiting confirmation of device discardment.The review of the manufacturing paperwork verified that the lot met all pre-release specifications.
 
Event or Problem Description
The following information was reported to gore using an fda implanted and explanted devices form: it was reported that a conformable gore® tag® thoracic endoprosthesis (ctag) was used to treat an unknown etiology.On (b)(6) 2019 the ctag device (lot #16103109) was reportedly implanted and explanted.The fda implanted and explanted devices form lists "patient anatomy" as the reason for action.No further event information was provided.Further investigation is required.
 
Additional Manufacturer Narrative
Conclusions code 2 updated.Conclusions code 2: code 4315- the physician's office responded that no further information would be provided.Therefore, the cause for device implant and explant was not established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8538142
Report Number2017233-2019-00270
Device Sequence Number16233373
Product Code MIH
UDI-Device Identifier00733132617746
UDI-Public00733132617746
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/28/2020
Device Catalogue NumberTGU454510
Device Lot Number16103109
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/22/2019
Supplement Report FDA Received Date06/17/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age62 YR
-
-